Atlas Trials

A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer

Clinical trial NCT04254497 · COMPLETED

Trial details

NCT number
NCT04254497
Sponsor
Changi General Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Lung Cancer
Start date
2014-09-11
Primary completion
2019-08-27
Enrollment
71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.